001     124366
005     20240228145508.0
024 7 _ |a 10.1093/neuonc/now101
|2 doi
024 7 _ |a pmid:27282398
|2 pmid
024 7 _ |a pmc:PMC5464243
|2 pmc
024 7 _ |a 1522-8517
|2 ISSN
024 7 _ |a 1523-5866
|2 ISSN
024 7 _ |a altmetric:8625129
|2 altmetric
037 _ _ |a DKFZ-2017-01245
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Jones, Chris
|b 0
245 _ _ |a Pediatric high-grade glioma: biologically and clinically in need of new thinking.
260 _ _ |a Oxford
|c 2017
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1661774452_6884
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a High-grade gliomas in children are different from those that arise in adults. Recent collaborative molecular analyses of these rare cancers have revealed previously unappreciated connections among chromatin regulation, developmental signaling, and tumorigenesis. As we begin to unravel the unique developmental origins and distinct biological drivers of this heterogeneous group of tumors, clinical trials need to keep pace. It is important to avoid therapeutic strategies developed purely using data obtained from studies on adult glioblastoma. This approach has resulted in repetitive trials and ineffective treatments being applied to these children, with limited improvement in clinical outcome. The authors of this perspective, comprising biology and clinical expertise in the disease, recently convened to discuss the most effective ways to translate the emerging molecular insights into patient benefit. This article reviews our current understanding of pediatric high-grade glioma and suggests approaches for innovative clinical management.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Karajannis, Matthias A
|b 1
700 1 _ |a Jones, David
|0 P:(DE-He78)551bb92841f634070997aa168d818492
|b 2
|u dkfz
700 1 _ |a Kieran, Mark W
|b 3
700 1 _ |a Monje, Michelle
|b 4
700 1 _ |a Baker, Suzanne J
|b 5
700 1 _ |a Becher, Oren J
|b 6
700 1 _ |a Cho, Yoon-Jae
|b 7
700 1 _ |a Gupta, Nalin
|b 8
700 1 _ |a Hawkins, Cynthia
|b 9
700 1 _ |a Hargrave, Darren
|b 10
700 1 _ |a Haas-Kogan, Daphne A
|b 11
700 1 _ |a Jabado, Nada
|b 12
700 1 _ |a Li, Xiao-Nan
|b 13
700 1 _ |a Mueller, Sabine
|b 14
700 1 _ |a Nicolaides, Theo
|b 15
700 1 _ |a Packer, Roger J
|b 16
700 1 _ |a Persson, Anders I
|b 17
700 1 _ |a Phillips, Joanna J
|b 18
700 1 _ |a Simonds, Erin F
|b 19
700 1 _ |a Stafford, James M
|b 20
700 1 _ |a Tang, Yujie
|b 21
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 22
|u dkfz
700 1 _ |a Weiss, William A
|b 23
773 _ _ |a 10.1093/neuonc/now101
|g Vol. 19, no. 2, p. now101 -
|0 PERI:(DE-600)2094060-9
|n 2
|p 153-161
|t Neuro-Oncology
|v 19
|y 2017
|x 1523-5866
909 C O |p VDB
|o oai:inrepo02.dkfz.de:124366
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)551bb92841f634070997aa168d818492
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Functional and structural genomics
|x 0
914 1 _ |y 2017
915 _ _ |a Allianz-Lizenz / DFG
|0 StatID:(DE-HGF)0400
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURO-ONCOLOGY : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NEURO-ONCOLOGY : 2015
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21